Drugs Made In America Acquisition (DMIIR) Treasury Shares (2024 - 2025)

Drugs Made In America Acquisition's (DMIIR) quarterly Treasury Shares came in at $50.0 million in Q4 2025, little changed year-on-year from $50.0 million in Q4 2024, and little changed on a QoQ basis from $50.0 million in Q3 2025.

Drugs Made In America Acquisition (DMIIR) Treasury Shares (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has 2 years of Treasury Shares data on file, last reported at $50.0 million in Q4 2025.

  • On a quarterly basis, Treasury Shares changed 0.0% year-over-year to $50.0 million in Q4 2025; TTM through Dec 2025 was $50.0 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $50.0 million, changed 0.0% from the prior year.
  • Treasury Shares for Q4 2025 stood at $50.0 million, roughly flat from $50.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for DMIIR reached as high as $50.0 million in Q4 2024 and fell as low as $50.0 million in Q4 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 EQV Ventures Acquisition 480.75 Mn 480.75 Mn - 46.00 Mn
2 Agriculture & Natural Solutions Acquisition 393.29 Mn 393.29 Mn - 32.92 Mn
3 Berto Acquisition 314.56 Mn 314.35 Mn - 30.02 Mn
4 GP-Act III Acquisition 313.66 Mn 313.66 Mn - 28.75 Mn
5 Centurion Acquisition 311.65 Mn 311.65 Mn - -
6 Republic Digital Acquisition 310.50 Mn 309.63 Mn - -
7 Siddhi Acquisition Corp (Cayman Islands) 288.97 Mn 288.97 Mn - -
8 K&F Growth Acquisition 283.42 Mn 283.42 Mn - 28.75 Mn
9 Bold Eagle Acquisition 275.29 Mn 275.29 Mn - 25.80 Mn
10 Drugs Made In America Acquisition - - - 50.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 50.00 Mn
Dec 31, 2025 50.00 Mn
Sep 30, 2025 50.00 Mn
Sep 30, 2025 50.00 Mn
Dec 31, 2024 50.00 Mn
Dec 31, 2024 50.00 Mn